Work

The Biology of Cyclic GMP-dependent Protein Kinases

Year: 2004
Type: review
Abstract: cGKs 1The abbreviations used are: cGK, cGMP-dependent protein kinase; [Ca2+]i, intracellular Ca2+ concentration; 8-Br-cGMP, 8-bromo-cGMP; IP3, inositol 1,4,5-trisphosphate; MLCK, myosin light chain kinase; RLC, regulatory myosin light chain; MLCP, myosin light chain phosphatase; IRAG, IP3 receptor-associated cGKI substrate; MBS, myosin-binding subunit; MYPT, myosin/phosphatase-targeting subunit; VASP, vasodilator-stimulated phosphoprotein; STa, heat-stable enterotoxin of Escherichia coli; SCN, suprachiasmatic nucleus. belong to the family of serine/threonine kinases and are present in a variety of eukaryotes ranging from the unicellular organism Paramecium to Homo sapiens (1Pfeifer A. Ruth P. Dostmann W. Sausbier M. Klatt P. Hofmann F. Rev. Physiol. Biochem. Pharmacol. 1999; 135: 105-149Crossref PubMed Google Scholar, 2Francis S.H. Corbin J.D. Crit. Rev. Clin. Lab. Sci. 1999; 36: 275-328Crossref PubMed Scopus (261) Google Scholar). Mammals have two cGK genes, prkg1 and prkg2, that encode cGKI and cGKII. The N terminus (the first 90-100 residues) of cGKI is encoded by two alternatively spliced exons that produce the isoforms cGKIα and cGKIβ. The enzymes have a rod-like structure and are activated at submicromolar to micromolar concentrations of cGMP (3Ruth P. Pfeifer A. Kamm S. Klatt P. Dostmann W.R. Hofmann F. J. Biol. Chem. 1997; 272: 10522-10528Abstract Full Text Full Text PDF PubMed Scopus (58) Google Scholar, 4Gamm D.M. Francis S.H. Angelotti T.P. Corbin J.D. Uhler M.D. J. Biol. Chem. 1995; 270: 27380-27388Abstract Full Text Full Text PDF PubMed Scopus (95) Google Scholar). They are composed of three functional domains: an N-terminal (A) domain, a regulatory (R) domain, and a catalytic (C) domain (for details see Refs. 1Pfeifer A. Ruth P. Dostmann W. Sausbier M. Klatt P. Hofmann F. Rev. Physiol. Biochem. Pharmacol. 1999; 135: 105-149Crossref PubMed Google Scholar and 2Francis S.H. Corbin J.D. Crit. Rev. Clin. Lab. Sci. 1999; 36: 275-328Crossref PubMed Scopus (261) Google Scholar). The regulatory domain contains two tandem cGMP-binding sites that interact allosterically and bind cGMP with high and low affinity. Occupation of both binding sites induces a large change in secondary structure (5Landgraf W. Hofmann F. Pelton J.T. Huggins J.P. Biochemistry. 1990; 29: 9921-9928Crossref PubMed Scopus (35) Google Scholar) to yield a more elongated molecule (6Zhao J. Trewhella J. Corbin J. Francis S. Mitchell R. Brushia R. Walsh D. J. Biol. Chem. 1997; 272: 31929-31936Abstract Full Text Full Text PDF PubMed Scopus (53) Google Scholar, 7Wall M.E. Francis S.H. Corbin J.D. Grimes K. Richie-Jannetta R. Kotera J. Macdonald B.A. Gibson R.R. Trewhella J. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 2380-2385Crossref PubMed Scopus (61) Google Scholar). The catalytic domain contains the MgATP- and peptide-binding pockets. Binding of cGMP to both sites in the R domain releases the inhibition of the catalytic center by the N-terminal autoinhibitory/pseudosubstrate site and allows the phosphorylation of serine/threonine residues in target proteins and in the N-terminal autophosphorylation site. Activation of heterophosphorylation may be preceded by autophosphorylation. Autophosphorylation increases the spontaneous activity of cGKI and cGKII (8Smith J.A. Francis S.H. Walsh K.A. Kumar S. Corbin J.D. J. Biol. Chem. 1996; 271: 20756-20762Abstract Full Text Full Text PDF PubMed Scopus (73) Google Scholar, 9Wyatt T.A. Lincoln T.M. Pryzwansky K.B. J. Biol. Chem. 1991; 266: 21274-21280Abstract Full Text PDF PubMed Google Scholar, 10Vaandrager A.B. Hogema B.M. van den Edixhoven M. Burg C.M. Bot A.G. Klatt P. Ruth P. Hofmann F. Van Damme J. Vandekerckhove J. de Jonge H.R. J. Biol. Chem. 2003; 278: 28651-28658Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar, 11Francis S.H. Poteet-Smith C. Busch J.L. Richie-Jannetta R. Corbin J.D. Front Biosci. 2002; 7: d580-d592Crossref PubMed Google Scholar) and is initiated by the binding of low cGMP concentrations to the high affinity site of cGKI (12Hofmann F. Gensheimer H.P. Gobel C. Eur. J. Biochem. 1985; 147: 361-365Crossref PubMed Scopus (52) Google Scholar, 13Smith J.A. Reed R.B. Francis S.H. Grimes K. Corbin J.D. J. Biol. Chem. 2000; 275: 154-158Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar). In addition to controlling activation and inhibition of the catalytic center, the N terminus has two other functions: dimerization, cGKs are homodimers that are held together by a leucine zipper present in the N terminus, and targeting, the enzymes are targeted to different subcellular localizations by their N termini. cGKI is present in high concentrations (>0.1 μm) in all smooth muscles, platelets, cerebellum, hippocampus, dorsal root ganglia, neuromuscular endplate, and kidney. Low levels have been identified in cardiac muscle, vascular endothelium, granulocytes, chondrocytes, and osteoclasts. The Iα isozyme is found in lung, heart, dorsal root ganglia, and cerebellum. Together with the Iα isozyme, the Iβ isozyme is highly expressed in smooth muscle, including uterus, vessels, intestine, and trachea (14Geiselhoringer A. Gaisa M. Hofmann F. Schlossmann J. FEBS Lett. 2004; 575: 19-22Crossref PubMed Scopus (81) Google Scholar). Platelets, hippocampal neurons, and olfactory bulb neurons contain mainly the Iβ isozyme (14Geiselhoringer A. Gaisa M. Hofmann F. Schlossmann J. FEBS Lett. 2004; 575: 19-22Crossref PubMed Scopus (81) Google Scholar). The Iα and Iβ cGKs are soluble enzymes and interact with different proteins through their distinct N termini. cGKII is expressed in several brain nuclei, intestinal mucosa, kidney, adrenal cortex, chondrocytes, and lung (15el-Husseini A.E. Bladen C. Vincent S.R. J. Neurochem. 1995; 64: 2814-2817Crossref PubMed Scopus (87) Google Scholar, 16Lohmann S.M. Vaandrager A.B. Smolenski A. Walter U. De Jonge H.R. Trends Biochem. Sci. 1997; 22: 307-312Abstract Full Text PDF PubMed Scopus (352) Google Scholar, 17de Vente J. Asan E. Markerink-van Gambaryan S. Ittersum M. Axer H. Gallatz K. Lohmann S.M. Palkovits M. Neuroscience. 2001; 108: 27-49Crossref PubMed Scopus (68) Google Scholar, 18Werner C. Raivich G. Cowen M. Stekalowa T. Sillaber I. Buters J.T. Spanagel R. Hofmann F. Eur. J. Neurosci. 2004; (in press)Google Scholar). cGKII is anchored at the plasma membrane by myristoylation of the N-terminal Gly-2 residue. Only the membrane-bound cGKII phosphorylates cystic fibrosis transmembrane conductance regulator (19Vaandrager A.B. Smolenski A. Tilly B.C. Houtsmuller A.B. Ehlert E.M. Bot A.G. Edixhoven M. Boomaars W.E. Lohmann S.M. de Jonge H.R. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 1466-1471Crossref PubMed Scopus (145) Google Scholar). Control of Smooth Muscle Tone by cGKI—NO and other NO-generating organic nitrates stimulate the soluble guanylyl cyclase, increase cGMP levels, and thereby relax vascular and other smooth muscles. The relaxing effect of these compounds involves the activation of cGKI as shown by deleting the cGKI gene in mice (20Pfeifer A. Klatt P. Massberg S. Ny L. Sausbier M. Hirneiss C. Wang G.X. Korth M. Aszodi A. Andersson K.E. Krombach F. Mayerhofer A. Ruth P. Fassler R. Hofmann F. EMBO J. 1998; 17: 3045-3051Crossref PubMed Scopus (455) Google Scholar). cGKI-deficient mice are hypertensive at 4 weeks but normotensive at an older age (20Pfeifer A. Klatt P. Massberg S. Ny L. Sausbier M. Hirneiss C. Wang G.X. Korth M. Aszodi A. Andersson K.E. Krombach F. Mayerhofer A. Ruth P. Fassler R. Hofmann F. EMBO J. 1998; 17: 3045-3051Crossref PubMed Scopus (455) Google Scholar, 21Koeppen M. Feil R. Siegl D. Feil S. Hofmann F. Pohl U. de Wit C. Hypertension. 2004; 44: 952-955Crossref PubMed Scopus (64) Google Scholar). The blood pressure-lowering effect of intraarterial infusion of sodium nitroprusside is abolished in cGKI-deficient mice whereas acetylcholine infusion still lowers the blood pressure (21Koeppen M. Feil R. Siegl D. Feil S. Hofmann F. Pohl U. de Wit C. Hypertension. 2004; 44: 952-955Crossref PubMed Scopus (64) Google Scholar) suggesting that cGKI is involved in the control of vascular tone but that additional mechanisms exist. Precontracted smooth muscle strips or pressurized vessels of cGKI-deficient mice are not relaxed by acetylcholine or NO (20Pfeifer A. Klatt P. Massberg S. Ny L. Sausbier M. Hirneiss C. Wang G.X. Korth M. Aszodi A. Andersson K.E. Krombach F. Mayerhofer A. Ruth P. Fassler R. Hofmann F. EMBO J. 1998; 17: 3045-3051Crossref PubMed Scopus (455) Google Scholar, 22Sausbier M. Schubert R. Voigt V. Hirneiss C. Pfeifer A. Korth M. Kleppisch T. Ruth P. Hofmann F. Circ. Res. 2000; 87: 825-830Crossref PubMed Scopus (206) Google Scholar). The defective regulation of smooth muscle tone is not confined to vascular smooth muscle but is also found in other organs. In the gastrointestinal tract, accommodation of food and generation of peristaltic waves are controlled by nonadrenergic-noncholinergic neurons, which release NO upon stimulation and relax the intestinal smooth muscle. Deletion of the cGKI gene leads to pylorus stenosis, causing severe distention of the stomach and irregular peristaltic waves that heavily retard passage of intestinal content. Deletion of cGKI did not affect cAMP-induced relaxation of vascular or intestinal smooth muscle supporting the conclusion that cAMP and cGMP use different signal pathways in smooth muscle. Smooth muscle tone is regulated by the rise and fall of [Ca2+]i. Contraction is initiated by receptor-mediated generation of IP3 that releases Ca2+ from intracellular stores followed by an influx of extracellular Ca2+ through voltage-dependent Ca2+ channels (23Moosmang S. Schulla V. Welling A. Feil R. Feil S. Wegener J.W. Hofmann F. Klugbauer N. EMBO J. 2003; 22: 6027-6034Crossref PubMed Scopus (248) Google Scholar, 24Wegener J.W. Schulla V. Lee T.S. Koller A. Feil S. Feil R. Kleppisch T. Klugbauer N. Moosmang S. Welling A. Hofmann F. Faseb. J. 2004; 18: 1159-1161Crossref PubMed Scopus (93) Google Scholar). The rise in [Ca2+]i initiates contraction by activation of the Ca2+/calmodulin-dependent MLCK, which phosphorylates RLC and, consequently, activates myosin ATPase. A decrease in [Ca2+]i inactivates MLCK and induces dephosphorylation of RLC by MLCP. Smooth muscle contraction is modulated also at constant [Ca2+]i by changing the sensitivity of contraction to [Ca2+] (25Somlyo A.P. Somlyo A.V. Physiol. Rev. 2003; 83: PubMed Scopus Google Scholar). cGKI both with the increase in [Ca2+]i and with the Ca2+ sensitivity at several levels that cGKIα the generation of IP3 in smooth muscle and P. Wang G.X. I. Pfeifer A. R. Korth M. H. Hofmann F. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar) by with the of Wang P. M. M.E. 2003; PubMed Scopus Google Scholar) or the activation of C. C. B.M. M. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). the of these a the cGMP-dependent phosphorylation of a target protein and IP3 has not been The IP3 has two the and the that is expressed in smooth muscle. are in and in at two by cAMP and cGKI phosphorylates P. Lincoln T.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar). that phosphorylation of the IP3 in a release of Ca2+ from intracellular that phosphorylation of in an Ca2+ release J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). cGMP-dependent phosphorylation of the IP3 effect Ca2+ whereas Ca2+ release from the J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). that cGMP-dependent phosphorylation of the IP3 is not smooth muscle tone regulation but may be neurons that cGKI but not cGKI (14Geiselhoringer A. Gaisa M. Hofmann F. Schlossmann J. FEBS Lett. 2004; 575: 19-22Crossref PubMed Scopus (81) Google Scholar). The smooth muscle IP3 with and a protein identified as J. A. K. A. G. Wang G.X. Korth M. M. Hofmann F. Ruth P. 2000; PubMed Scopus Google Scholar). is expressed together with in smooth muscle, platelets, and neurons (14Geiselhoringer A. Gaisa M. Hofmann F. Schlossmann J. FEBS Lett. 2004; 575: 19-22Crossref PubMed Scopus (81) Google Scholar). is at the membrane and is by at and A. M. K. P. R. L. J. P. Feil R. Feil S. Wegener J. Hofmann F. Schlossmann J. EMBO J. 2004; PubMed Scopus Google Scholar, A. A. Hofmann F. Schlossmann J. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). phosphorylation of Ca2+ release in and The and with the leucine zipper of A. A. Hofmann F. Schlossmann J. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). has a domain that in with the IP3 A. M. K. P. R. L. J. P. Feil R. Feil S. Wegener J. Hofmann F. Schlossmann J. EMBO J. 2004; PubMed Scopus Google Scholar). Deletion of that the N-terminal of the domain in a A. M. K. P. R. L. J. P. Feil R. Feil S. Wegener J. Hofmann F. Schlossmann J. EMBO J. 2004; PubMed Scopus Google Scholar). relaxation of and contraction of and muscle is abolished in these In not Ca2+ in smooth muscle of A. M. K. P. R. L. J. P. Feil R. Feil S. Wegener J. Hofmann F. Schlossmann J. EMBO J. 2004; PubMed Scopus Google Scholar). relaxation of smooth muscle contraction is in the In is to affect Ca2+ release and contraction in smooth from cGKI-deficient the first that cGKI has in that to smooth muscle relaxation additional that lowers [Ca2+]i is the phosphorylation of channels by at constant [Ca2+]i A. M. Hofmann F. Ruth P. P. L. J. Biol. Chem. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar, M. J.L. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). The cGKI isozyme that phosphorylates channels is not of channels the membrane and a of including thereby Ca2+ to the regulation of vascular as shown in and cGKI-deficient mice M. Schubert R. Voigt V. Hirneiss C. Pfeifer A. Korth M. Kleppisch T. Ruth P. Hofmann F. Circ. Res. 2000; 87: 825-830Crossref PubMed Scopus (206) Google Scholar). The regulation of channels Schlossmann J. Hofmann F. Ruth P. Korth M. 1998; PubMed Scopus Google Scholar) and may be by activation of an protein Ruth P. Schlossmann J. Hofmann F. Korth M. J. Biol. Chem. 1996; 271: Full Text Full Text PDF PubMed Scopus Google Scholar, Lee A.B. Lincoln T.M. A. PubMed Scopus Google Scholar). of channels the of to relax smooth muscle strips of the A. M. K. P. R. L. J. P. Feil R. Feil S. Wegener J. Hofmann F. Schlossmann J. EMBO J. 2004; PubMed Scopus Google a change in activity not affect the membrane these target cGKI is smooth muscle tone is by dephosphorylation of the RLC M. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). is a a regulatory also identified as myosin a catalytic and a protein of M. F. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). have shown that the inhibition of activity be to Ca2+ sensitivity of smooth muscle in regulatory are and protein and M. F. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). of at by or the activity of phosphorylation of RLC and contraction at constant [Ca2+]i (25Somlyo A.P. Somlyo A.V. Physiol. Rev. 2003; 83: PubMed Scopus Google Scholar, M. F. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). is by cGKIα at several sites N. M. Lincoln T.M. M.E. 1999; PubMed Scopus Google Scholar, M. K. M. T. N. S. T. 1999; PubMed Scopus (52) Google Scholar). cGKIα is targeted by leucine zipper to N. M. Lincoln T.M. M.E. 1999; PubMed Scopus Google Scholar). phosphorylation of at the phosphorylation at and thereby the decrease in activity J.A. F. C. T.A. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). a in RLC phosphorylation and relaxation at constant [Ca2+]i. The of the mechanisms smooth muscle tone in different Deletion of the cGKI gene and of of the gene that phosphorylation of IRAG, and in the has been shown that of the Ca2+ sensitivity is in smooth from the intestine, whereas regulation of the [Ca2+]i to be more in vascular smooth muscle. In these that NO through cGKIα and in smooth muscle and that these use different to affect smooth muscle of Smooth Muscle and of vascular smooth muscle are to be in the of and vascular have that and cGMP and of vascular smooth muscle A. J. Clin. 83: PubMed Scopus Google Scholar, A. C.M. N. J. Clin. 1998; PubMed Scopus Google Scholar). that cGKI gene through the extracellular protein by stimulation or by inhibition F. A. Schlossmann J. J. Sci. 2000; PubMed Google Scholar, R.B. Circ. Res. 2003; PubMed Scopus Google Scholar). phosphorylation of be in these VASP, a of the is an protein that is to the and in M. Lohmann S.M. Walter U. R.B. Rev. Physiol. Biochem. Pharmacol. 1999; 135: PubMed Google Scholar). is by protein cAMP and cGKI at two sites with different that of and phosphorylation of whereas phosphorylation of L. G. K. M. Walter U. Biol. 2004; PubMed Scopus Google Scholar). as used in phosphorylation of of through K. L. A. Walter U. G. FEBS Lett. 2004; PubMed Scopus Google an effect of not In a of the of cGKI K. H. J. N. M. T. K. H. H. Feil R. Hofmann F. K. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: PubMed Scopus Google Scholar). In a of found W. Feil S. S. Hofmann F. Feil R. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: PubMed Scopus (68) Google Scholar) that smooth of cGKI the of and smooth muscle in In W. Feil S. S. Hofmann F. Feil R. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: PubMed Scopus (68) Google that stimulation of cGKI smooth muscle in whereas NO of is that in cGKI smooth muscle and that the as as controlled are of is initiated at the has been release and which and cAMP and cGMP levels in and thereby have a high of that is activated in to NO and has an S. Sausbier M. Klatt P. M. Pfeifer A. W. Fassler R. Ruth P. Krombach F. Hofmann F. J. 1999; PubMed Scopus Google Scholar, Feil R. Hofmann F. G. J.T. F. 2004; PubMed Scopus Google Scholar, S. J. E. A. A. Walter U. 2004; PubMed Scopus Google Scholar). cGKI may also activation M. Feil R. M. Hofmann F. 2003; Full Text Full Text PDF PubMed Scopus Google by the release of G. J.A. C. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). NO or cGMP did not of cGKI-deficient platelets, whereas by S. Sausbier M. Klatt P. M. Pfeifer A. W. Fassler R. Ruth P. Krombach F. Hofmann F. J. 1999; PubMed Scopus Google Scholar). is to in S. Sausbier M. Klatt P. M. Pfeifer A. W. Fassler R. Ruth P. Krombach F. Hofmann F. J. 1999; PubMed Scopus Google Scholar). contain two cGKI and Deletion of the gene in mice did not affect A. Pfeifer A. M. M. Ny L. Andersson K.E. S. Fassler R. EMBO J. 1999; 18: PubMed Scopus Google Scholar, W. M. Gambaryan S. V. J. M. E. I. Walter U. M. Proc. Natl. Acad. Sci. U. S. A. 1999; PubMed Scopus Google but the of with the in S. S. I. M. K. J. C. I. F. U. Walter U. M. 2004; PubMed Scopus Google Scholar). Activation of cGKI the release of Ca2+ from stores in and to A. Pfeifer A. M. M. Ny L. Andersson K.E. S. Fassler R. EMBO J. 1999; 18: PubMed Scopus Google Scholar). (14Geiselhoringer A. Gaisa M. Hofmann F. Schlossmann J. FEBS Lett. 2004; 575: 19-22Crossref PubMed Scopus (81) Google Scholar). from the mice A. M. K. P. R. L. J. P. Feil R. Feil S. Wegener J. Hofmann F. Schlossmann J. EMBO J. 2004; PubMed Scopus Google Scholar, A. M. K. P. R. L. J. P. Feil R. Feil S. Wegener J. Hofmann F. Schlossmann J. EMBO J. 2004; PubMed Scopus Google Scholar) have a severe in the of F. and J. that is an of the of cGKII is at a Only three have been identified cGKII a and is by that stimulate cAMP or cGMP cGKII is highly expressed in the membrane of the of the The of mice to cAMP whereas cGKII cystic fibrosis transmembrane conductance regulator and and that cGKII is in the A. Aszodi A. U. Ruth P. Hofmann F. Fassler R. 1996; PubMed Scopus Google Scholar, A.B. Bot A.G. Ruth P. Pfeifer A. Hofmann F. De Jonge H.R. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). to release in the kidney. Deletion of the cGKI gene effect release in or whereas the effect of NO release in mice C. Pfeifer A. Ruth P. Hofmann F. A. J. Clin. 1998; PubMed Scopus Google Scholar). pressure not in is that activation of cGKII the of in adrenal S. E. K. M. A. G. Smolenski A. J. Biol. Chem. 2003; 278: Full Text Full Text PDF PubMed Scopus Google Scholar). is that the effect of cGKII two blood other in the and are expressed in and M. K. N. A. T. M. H. H. K. K. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: PubMed Scopus Google Scholar). of in the of a and a increase in mice which to that by cGKI and are expressed in the of A. Aszodi A. U. Ruth P. Hofmann F. Fassler R. 1996; PubMed Scopus Google Scholar). The of cGKI has effect the of the (20Pfeifer A. Klatt P. Massberg S. Ny L. Sausbier M. Hirneiss C. Wang G.X. Korth M. Aszodi A. Andersson K.E. Krombach F. Mayerhofer A. Ruth P. Fassler R. Hofmann F. EMBO J. 1998; 17: 3045-3051Crossref PubMed Scopus (455) Google Scholar). In mice are with cGKII is the T. H. A. N. Pfeifer A. Hofmann F. K. 2002; PubMed Scopus Google Scholar) and suprachiasmatic the that a to and is to the by pathways S.M. 2002; PubMed Scopus Google Scholar). cGKs are expressed in the with mice that cGKII the of the at the of the activity H. C. H. Feil R. Hofmann F. U. Biol. 2003; Full Text Full Text PDF PubMed Scopus Google Scholar). The of cGKII in the regulation of the S.M. Mitchell J.W. J. Neurosci. 2003; PubMed Google Scholar) in the SCN, in that cGKII to of the Mitchell J.W. J.W. J.A. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). cGKs and the cGKII is expressed in neurons, of the gene in as a and a to C. Raivich G. Cowen M. Stekalowa T. Sillaber I. Buters J.T. Spanagel R. Hofmann F. Eur. J. Neurosci. 2004; (in press)Google Scholar). the of cGKI is a of are with of cGKI (for an see R. Hofmann F. Kleppisch T. Rev. Neurosci. 2004; (in press)Google Scholar). cGKIα expressed in neurons of dorsal root is the of H. M. M. S. Hofmann F. Feil R. J. Biol. 2002; PubMed Scopus Google Scholar). that cGKIα is also involved in of I. D. A. Sausbier M. Feil R. Hofmann F. T. Ruth P. G. Proc. Natl. Acad. Sci. U. S. A. 2004; PubMed Scopus Google Scholar). is involved in hippocampal a as shown in I. Gambaryan S. Lohmann S.M. J. Neurosci. 2001; PubMed Google Scholar) and in cGKI mice T. W. Feil S. R. S. K.A. Hofmann F. Feil R. J. Neurosci. 2003; PubMed Google Scholar). The of is the cGKI in several T. W. Feil S. R. S. K.A. Hofmann F. Feil R. J. Neurosci. 2003; PubMed Google Scholar). The of cGKI in hippocampal and dorsal root neurons are neurons high levels of cGKIα and the a by The is an of protein D.M. E. Uhler M.D. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, S. M. M. R. K. P. M. Proc. Natl. Acad. Sci. U. S. A. 1999; PubMed Scopus (64) Google Scholar). has been that inhibition of the protein allows phosphorylation of the by other kinases and to of an increase in [Ca2+]i and cGKIα activity is of V. J.P. 1995; Full Text PDF PubMed Scopus Google Scholar) and R. J. C. W. K. Feil S. M. A. De Hofmann F. J. Biol. 2003; PubMed Scopus Google Scholar). and also identified in a large of has two cGK genes, and D. J. Biol. Chem. Full Text PDF PubMed Google Scholar). a protein that is to the cGKI gene (1Pfeifer A. Ruth P. Dostmann W. Sausbier M. Klatt P. Hofmann F. Rev. Physiol. Biochem. Pharmacol. 1999; 135: 105-149Crossref PubMed Google Scholar, Biol. 2004; 44: PubMed Scopus Google Scholar). of in that a high activity of the is a of K.A. A. E. S. A. 1997; PubMed Scopus Google Scholar). A has been identified in A activity is the change from to A. 2002; PubMed Scopus Google Scholar). The change has been found in In these food is with a cGK activity M. P. 2002; 36: Full Text Full Text PDF PubMed Scopus Google Scholar). the cGK gene involved in is more to cGKII to cGKI Biol. 2004; 44: PubMed Scopus Google Scholar) to the that cGKII activity is to a in The that cGKs are involved not in but also and that in cGK to Feil the
Language: English
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W2034832260
FWCI: 1.174
Cites: 82
Cited by: 251
Related to: 10